These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing. Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341 [TBL] [Abstract][Full Text] [Related]
29. IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy. Li H; Li J; Cheng G; Zhang J; Li X Clin Neurol Neurosurg; 2016 Dec; 151():31-36. PubMed ID: 27764705 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes. Patil V; Mahalingam K Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645 [TBL] [Abstract][Full Text] [Related]
31. IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy. Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Yamaguchi S; Tanino M; Murata J; Houkin K Brain Tumor Pathol; 2013 Apr; 30(2):67-72. PubMed ID: 22752663 [TBL] [Abstract][Full Text] [Related]
32. Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis. Easwaran TP; Lancki N; Henriquez M; Vortmeyer AO; Barbaro NM; Scholtens DM; Ahmed AU; Dey M Neuromolecular Med; 2021 Jun; 23(2):315-326. PubMed ID: 33206320 [TBL] [Abstract][Full Text] [Related]
33. Somatic mutations associated with MRI-derived volumetric features in glioblastoma. Gutman DA; Dunn WD; Grossmann P; Cooper LA; Holder CA; Ligon KL; Alexander BM; Aerts HJ Neuroradiology; 2015 Dec; 57(12):1227-37. PubMed ID: 26337765 [TBL] [Abstract][Full Text] [Related]
34. Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival. Ye S; Zhou S; Wu Y; Pei X; Jiang W; Shi W; Yang W; Zhou X; Shan B; Yang H Ann Med; 2023 Dec; 55(1):2218104. PubMed ID: 37272300 [TBL] [Abstract][Full Text] [Related]
35. TP53 Mutation and Extraneural Metastasis of Glioblastoma: Insights From an Institutional Experience and Comprehensive Literature Review. Zhang X; Katsakhyan L; LiVolsi VA; Roth JJ; Rassekh CH; Bagley SJ; Nasrallah MP Am J Surg Pathol; 2021 Nov; 45(11):1516-1526. PubMed ID: 34366423 [TBL] [Abstract][Full Text] [Related]
36. SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome. Hasselblatt M; Thomas C; Federico A; Nemes K; Johann PD; Bison B; Bens S; Dahlum S; Kordes U; Redlich A; Lessel L; Pajtler KW; Mawrin C; Schüller U; Nolte K; Kramm CM; Hinz F; Sahm F; Giannini C; Penkert J; Kratz CP; Pfister SM; Siebert R; Paulus W; Kool M; Frühwald MC Am J Surg Pathol; 2022 Sep; 46(9):1277-1283. PubMed ID: 35446794 [TBL] [Abstract][Full Text] [Related]
37. The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma. Liu X; Mangla R; Tian W; Qiu X; Li D; Walter KA; Ekholm S; Johnson MD J Neurooncol; 2017 Dec; 135(3):553-560. PubMed ID: 28889246 [TBL] [Abstract][Full Text] [Related]
38. A genomic score to predict local control among patients with brain metastases managed with radiation. Lamba N; Cagney DN; Catalano PJ; Kim D; Elhalawani H; Haas-Kogan DA; Wen PY; Wagle N; Aizer AA Neuro Oncol; 2023 Oct; 25(10):1815-1827. PubMed ID: 37260393 [TBL] [Abstract][Full Text] [Related]
39. Biallelic TP53 gain of function mutations in rapidly progressing solid tumors. Sande CM; Chang B; Monga V; Bossler AD; Ma D Cancer Genet; 2018 Apr; 222-223():20-24. PubMed ID: 29666004 [TBL] [Abstract][Full Text] [Related]
40. Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing. Cantero D; Rodríguez de Lope Á; Moreno de la Presa R; Sepúlveda JM; Borrás JM; Castresana JS; D'Haene N; García JF; Salmon I; Mollejo M; Rey JA; Hernández-Laín A; Meléndez B J Neuropathol Exp Neurol; 2018 Aug; 77(8):710-716. PubMed ID: 30010995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]